Research & Development



  “主政一方確實自由……”   那些出身比我們高貴的人還在努力拼命掙前程,而我們的孩子卻在坐享其成!97资源站   “那好吧,首功是你們五個人的,發丘中郎將需要老夫派出!”超碰97资源站   裴炎感慨了一聲,好像想到了什麼,疑惑的看著雲瑯。   雲瑯攤攤手道︰“那就沒辦法了……”色久久综合网   烽燧邊上有很多兩尺高的土堆,土堆上壓滿了石頭,匈奴人的招魂幡插在土堆上,正隨風飄舞。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo